What is the Vallon Pharmaceuticals, Inc. stock price forecast?

Vallon Pharmaceuticals, Inc. is currently trading at $2.17. View real-time AI analysis on Alpha Lenz.

What is Vallon Pharmaceuticals, Inc. insider trading activity?

View the latest insider trading data for Vallon Pharmaceuticals, Inc. on Alpha Lenz.

What is Vallon Pharmaceuticals, Inc.'s P/E ratio?

View Vallon Pharmaceuticals, Inc.'s valuation metrics on Alpha Lenz.

Vallon Pharmaceuticals, Inc.

NASDAQ · VLON

$2.17-0.12(-5.24%)Pre-market

Ask about Vallon Pharmaceuticals, Inc.'s future dividend policy...

Alpha Chat Insight

“Vallon Pharmaceuticals, Inc.'s ROE is 27.6%. Explore profitability and growth together.”

Ask for details →

Company Overview

Websitehttps://www.vallon-pharma.com

SectorUnknown

IndustryUnknown

Company Statistics

FY 2022

Profile

N/AMarket Cap

$0.00Revenue

0.00Shares Out

0Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-112.50%ROA

27.64%ROE

28.49%ROIC

Financial Health

$3.78MCash & Cash Equivalents

$-2.68MNet Debt

-3.80%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Vallon Pharmaceuticals, Inc.'s ROE is 27.6%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Vallon Pharmaceuticals, Inc. (ticker: VLON) is a company listed on NASDAQ in the Unknown sector (Unknown).

The current price is $2.17 with a P/E ratio of -x and P/B of -x.

ROE is 27.64%.